CAS 912628-39-8

Monoclonal IgG System Suitability

CAS : 912628-39-8

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Formule : C₆₃₃₄H₉₇₉₂N₁₇₀₀O₂₀₀₀S₄₂

Couleur et forme : White Lyophilized Cake

Masse moléculaire : 143014.50475

Ref: 45-1445550

USP mAb 003, Monoclonal IgG1

CAS : 912628-39-8

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Couleur et forme : Colorless Clear Liquid

Masse moléculaire : 203.09061

Ref: 45-1445595

Drozitumab

CAS : 912628-39-8

Drozitumab (PRO 95780) is a fully humanized antibody targeting the death receptor DR5 for the study of triple-negative breast cancer.

Degré de pureté : 99.2% (SDS-PAGE); 98.9% (SEC-HPLC) - 99.2% (SDS-PAGE); 98.9% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 143.09 kDa

Ref: TM-T76802

Drozitumab

CAS : 912628-39-8

A human monoclonal antibidy targets TRAIL receptor DR5.

Ref: 3D-CLA1252